Groupe hospitalier Bretagne Sud — Lorient

Public research footprint of Groupe hospitalier Bretagne Sud, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Squamous Cell Carcinoma of the Head and Neck · Large Cell Neuroendocrine Carcinoma of the Lung · Patient With a Prescribed Endotest · Cutaneous Squamous Cell Carcinoma (CSCC)

Recently updated registry entries

NCT04747054 — Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed… (Recruiting)
NCT07661927 — Skipping Hormone Therapy in Low-Risk Early Breast Cancer (Recruiting)
NCT05609864 — Drug Wastage : Observational Study in the Operating Rooms of France (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Groupe hospitalier Bretagne Sud?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.